Related Experiment Video
Updated: Jul 18, 2026
11:15
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
The great multidrug-resistance paradox.
1Department of Pharmaceutical Sciences, University of Michigan College of Pharmacy, 428 Church Street, Ann Arbor, Michigan 48109, USA.
ACS Chemical Biology
|December 14, 2006
Summary
Multidrug resistance in cancer cells is not solely due to drug efflux pumps. Intracellular drug sequestration within organelles explains high drug levels in resistant cells, offering new therapeutic strategies.
Area of Science:
- Pharmacology
- Cancer Biology
- Cellular Mechanisms
Background:
- Traditional research on multidrug resistance (MDR) in tumor cells primarily focused on transmembrane drug transporters responsible for extruding drugs from the cell.
- This efflux mechanism alone fails to explain the high intracellular drug concentrations observed in many drug-resistant cancer cells.
Discussion:
- Recent studies highlight the critical role of intracellular drug sequestration within cytoplasmic organelles as a key mechanism contributing to MDR.
- This sequestration can maintain high intracellular drug levels despite active efflux, resolving paradoxical observations in resistant cell lines.
Key Insights:
- Drug sequestration in organelles is a significant factor in overcoming cancer cell multidrug resistance.
- Understanding cellular pharmacokinetics, including organelle sequestration, is crucial for developing effective cancer therapies.
Outlook:
- Exploiting cellular pharmacokinetic properties, such as organelle sequestration, offers a promising avenue for developing targeted therapies against drug-resistant cancers.
- Future research should focus on modulating organelle drug accumulation to re-sensitize resistant tumors to chemotherapy.
Related Concept Videos
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
00:57Antibiotic Selection
Overview
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...